Head, National Drug Discovery Centre
BSc (Hons) PhD Melbourne
Dr Jeff Mitchell is a medicinal chemist and holds a PhD from the University of Melbourne. He has more than 15 years’ pharmaceutical industry experience, specialising in the discovery and development of novel small-molecule drugs.
Before joining the Institute in 2015, Dr Mitchell was a Principal Scientist at Biota Pharmaceuticals, where he played a critical role on a number of small-molecule anti-infective projects. Among these were a human orthopneumovirus program, which progressed from hit to Phase 2 clinical trials in partnership with MedImmune and AstraZeneca, and a Clostridium difficile program that was successfully licensed to Taxis Pharmaceuticals.